Google DeepMind released AlphaProtein Novo (AP Novo), a generative diffusion pipeline for de novo enzyme design via structural motif scaffolding that co-generates protein structures and sequences cond…
Google DeepMind introduced SynthID Bio, a watermarking method that tags AI-generated proteins without damaging their function, and said it is the first time AI-designed proteins that are both watermar…
Google DeepMind announced SynthID Bio on Wednesday, a watermarking method that hides a secret-key signature in the amino-acid choices of AI-designed protein sequences and remains detectable after the …
Google DeepMind introduced SynthID Bio, a proof-of-concept watermarking method that embeds a detectable signature into AI-generated protein sequences and predicted 3D structures while preserving biolo…
Arm Holdings CEO Rene Haas said AI will find a cure for cancer within the next few decades by solving problems too complex for humans, such as modelling DNA markers impacted by cancer. Haas told the B…
Isomorphic Labs, the Alphabet spinoff, released IsoDDE on February 10, a unified drug design engine that achieves a 50% success rate on the hardest molecular prediction tasks, outperforming AlphaFold …
Apple Inc. has sent document retention letters to dozens of OpenAI employees as part of a widening trade secrets lawsuit that claims over 400 former Apple employees now work at OpenAI, threatening the…
Isomorphic Labs unveiled the Isomorphic Labs Drug Design Engine (IsoDDE), a unified computational drug-design system that more than doubles the accuracy of AlphaFold 3 on a challenging protein-ligand …
Google DeepMind's AlphaFold 3 predicts interactions among proteins, DNA, RNA, ligands, and other biomolecules, while Isomorphic Labs introduced the Isomorphic Drug Design Engine (IsoDDE) for drug disc…